2:1 Stock Split Ahead: IT Stock Hits 5% Upper Circuit On Completion of Its US-Based Project

With a market valuation of Rs 2,039.62 Cr, Blue Cloud Softech Solutions Ltd. is a small-cap company in the IT sector. On Monday, the shares of Blue Cloud Softech Solutions ended at a 5% upper circuit limit at Rs 93.50 per share compared to the previous close of Rs 89.05. Following the announcement of the successful completion of its most recent international project in the United States, Blue Cloud Softech Solutions Limited (BCS), a prominent supplier of state-of-the-art AIoT solutions and a business listed on the Bombay Stock Exchange (BSE), saw a surge in value.

BioSter, a sterilisation solution powered by artificial intelligence (AI), was deployed as part of this historic effort. This accomplishment was carried out at a project cost of USD 32,000.

Ms. Janaki Yarlagadda said, "The successful deployment of BioSter is a testament to our relentless pursuit of innovation in sterilization technology. BioSter's advanced AI capabilities not only enhance sterilization efficiency but also ensure unparalleled accuracy and reliability in sterilization Solutions. This project reinforces our standing as a global leader in AI-powered solutions, and we are confident that BioSter will continue to deliver exceptional value to our clients, improving both operational productivity and safety standards worldwide."

Ms. Janaki Yarlagadda further added that "Blue Cloud Softech Solutions Limited remains committed to delivering innovative and impactful solutions that bridge the gap between artificial intelligence and IoT, focusing on content integrity and verification while driving digital transformation across industries."

A Letter of Intent (LOI) to provide advanced Artificial Intelligence services to Renascent Logic Private Limited was recently obtained by Blue Cloud Softech Solutions Ltd (BCS) on December 19. The project is estimated to be worth Rs 105.00 lacs. Using state-of-the-art AI products like Access Genie, Blura, BluHealth, EduGenie, and the BioSter sterilisation system is part of the LOI's objective.

On the other hand, Blue Cloud Softech Solutions Limited (BCS) declared on December 18 that its most recent foreign project in the US had been completed successfully. The project, which cost USD 150,000, required implementing BLURA, a media communication platform powered by artificial intelligence (AI).

Following the announcement by Blue Cloud Softech Solutions on October 16, 2024, that the company's equity shares with face values of Rs. 2/- each (completely paid-up) would be sub-divided into one equity share with face values of Rs. 1/- each (fully paid-up), the aforementioned orders were carried out. A 2:1 stock split has the objective to increase the company's share price's liquidity on the stock exchange and make it easier for small investors to trade in the shares. The record date for the purpose of the same will be announced in due course of time.

Blue Cloud Softech Solutions Ltd (BCS), a cutting-edge supplier of AIoT solutions with its headquarters located in Hyderabad, Telangana, specialises in AI-based technologies and healthcare products.